News

News and Press Releases
About the CF Foundation Cystic Fibrosis Foundation Announces Irena Barisic as Next Chief Operating and Financial Officer

Barisic will transition from current role as Chief Financial and Administrative Officer in January 2023

| 3 min read
About the CF Foundation | Our Research Approach Cystic Fibrosis Foundation Invests $6M in Carbon Biosciences to Advance New Gene Therapy Approach for Cystic Fibrosis

Carbon Biosciences is the first company to publicly launch from the Foundation’s collaboration with Longwood Fund and the first to work alongside CF Foundation researchers at the Foundation’s therapeutics lab

| 4 min read
About the CF Foundation | Our Research Approach Cystic Fibrosis Foundation Invests $5 Million in Sionna Therapeutics to Develop New CFTR Modulator Therapy

New modulators in development by the CF-specific company could provide unique treatment options for the underlying cause of cystic fibrosis for many people with the disease

| 3 min read
About the CF Foundation | Researcher Resources Cystic Fibrosis Foundation Launches Inaugural Golden Ticket Competition to Find the Next Genetic Therapies for CF

Early stage researchers, life science entrepreneurs, and companies are encouraged to apply starting May 2

| 6 min read
Clinical Trials | Our Research Approach CF Foundation Funds Expansion of Clinical Trial Program for Potential Nonsense Mutations Therapy

The Cystic Fibrosis Foundation is awarding up to $15.9 million in additional funding to Eloxx Pharmaceuticals Inc. to expand clinical studies of ELX-02, a potential therapy for people with CF who have nonsense mutations.

| 4 min read
About the CF Foundation Cystic Fibrosis Foundation Names KC White as Next Chair of Board of Trustees

White will be the first person living with CF to lead the Board into a new era of CF

| 5 min read
About the CF Foundation Cystic Fibrosis Foundation Announces Steven Rowe, MD, as Next Chief Scientific Officer

Dr. Steven Rowe will support mission to cure cystic fibrosis by leading the Foundation’s research strategy, focusing on genetic therapies

| 4 min read
About the CF Foundation | Our Research Approach Cystic Fibrosis Foundation Announces Investment in SalioGen Therapeutics to Fund Genetic Therapies Research

Investment will support discovery research of a novel Gene CodingTM approach that could benefit all people with CF regardless of their mutation
 

| 5 min read
About the CF Foundation | Clinical Trials | Our Research Approach CF Foundation Awards Up to $5 Million to BiomX for Potential Phage Therapy

Study reaffirms the Foundation’s commitment to advance solutions to the growing challenge of antibiotic resistance

| 4 min read